With 9 hospitals already qualified and on boarded, I would expect the critical first 100 to be enrolled in not much more than a 1 week. Add 30 days and that's the most we have to wait.
However, if as expected Rem-L is getting patients out of critical care and ventilators in less than 10 days while the comparator of placebo maintains its current mortality rate of around a similar time frame, the data monitoring committee could be reporting in 3 weeks. So yes, agree with @Davisite that strong chance it will be stopped by end of May.
Ann: First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS, page-15
-
- There are more pages in this discussion • 174 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
-0.118(9.00%) |
Mkt cap ! $1.364B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.30 | $1.17 | $12.02M | 9.765M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 124844 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 26855 | 17 |
View Market Depth
| Last trade - 11.59am 24/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |